These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35635560)

  • 1. Platinum(IV) Prodrugs with Cancer Stem Cell Inhibitory Effects on Lung Cancer for Overcoming Drug Resistance.
    Wang X; Liu Z; Wang Y; Gou S
    J Med Chem; 2022 Jun; 65(11):7933-7945. PubMed ID: 35635560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel 4-Amino-Quinazoline moieties ligated Platinum(IV) prodrugs overcome cisplatin resistance in EGFR
    Li R; Zhao W; Jin C; Xiong H
    Bioorg Chem; 2023 Jun; 135():106499. PubMed ID: 37058978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Indole-Chalcone Derivative-Ligated Platinum(IV) Prodrugs Attenuate Cisplatin Resistance in Lung Cancer through ROS/ER Stress and Mitochondrial Dysfunction.
    Liu Z; Wang M; Huang R; Hu T; Jing Y; Huang X; Hu W; Cao G; Wang H
    J Med Chem; 2023 Apr; 66(7):4868-4887. PubMed ID: 36946996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel CK2-Specific Pt(II) Compound Reverses Cisplatin-Induced Resistance by Inhibiting Cancer Cell Stemness and Suppressing DNA Damage Repair in Non-small Cell Lung Cancer Treatments.
    Wang Y; Wang X; Xu G; Gou S
    J Med Chem; 2021 Apr; 64(7):4163-4178. PubMed ID: 33784109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cisplatin-based platinum(IV) prodrug containing a glutathione s-transferase inhibitor to reverse cisplatin-resistance in non-small cell lung cancer.
    Chen H; Wang X; Gou S
    J Inorg Biochem; 2019 Apr; 193():133-142. PubMed ID: 30731264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NEAT1 contributes to the CSC-like traits of A549/CDDP cells via activating Wnt signaling pathway.
    Jiang P; Xu H; Xu C; Chen A; Chen L; Zhou M; Haq IU; Wu X; Mariyam Z; Feng Q
    Chem Biol Interact; 2018 Dec; 296():154-161. PubMed ID: 30291867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Platinum(IV) complexes intervene oxaliplatin resistance in colon cancer via inducing ferroptosis and apoptosis.
    Liu Z; Cai J; Jiang G; Wang M; Wu C; Su K; Hu W; Huang Y; Yu C; Huang X; Cao G; Wang H
    Eur J Med Chem; 2024 Jan; 263():115968. PubMed ID: 37995563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-targeting antitumor conjugates derived from platinum(IV) prodrugs and microtubule inhibitor CA-4 significantly exhibited potent ability to overcome cisplatin resistance.
    Huang X; Wang M; Wang C; Hu W; You Q; Yang Y; Yu C; Liao Z; Gou S; Wang H
    Bioorg Chem; 2019 Nov; 92():103236. PubMed ID: 31494328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EHD1 confers resistance to cisplatin in non-small cell lung cancer by regulating intracellular cisplatin concentrations.
    Gao J; Meng Q; Zhao Y; Chen X; Cai L
    BMC Cancer; 2016 Jul; 16():470. PubMed ID: 27411790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting RAS-RAF pathway significantly improves antitumor activity of Rigosertib-derived platinum(IV) complexes and overcomes cisplatin resistance.
    Liu Z; Wang M; Wang H; Fang L; Gou S
    Eur J Med Chem; 2020 May; 194():112269. PubMed ID: 32248002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BBI608 inhibits cancer stemness and reverses cisplatin resistance in NSCLC.
    MacDonagh L; Gray SG; Breen E; Cuffe S; Finn SP; O'Byrne KJ; Barr MP
    Cancer Lett; 2018 Aug; 428():117-126. PubMed ID: 29653268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Nano-Platinum on Proliferation and Apoptosis of Non-Small Cell Lung Cancer Cells via P53 Pathway.
    Liu Y; Hu F; Zhao L
    J Nanosci Nanotechnol; 2021 Feb; 21(2):903-908. PubMed ID: 33183422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JARID2 promotes stemness and cisplatin resistance in non-small cell lung cancer via upregulation of Notch1.
    Wang Q; Wu J; Wei H; Huang H; Huang Y; Fang H; Gong X; Sun J; Wu Y; Lei C; Yu J; Hu D
    Int J Biochem Cell Biol; 2021 Sep; 138():106040. PubMed ID: 34246759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A platinum(II) complex HY1-Pt overcomes cisplatin-induced resistance and attenuates metastasis of epithelial ovarian cancer by cancer cell stemness inhibition.
    Wang X; Wang Y; Gou S
    Int J Biochem Cell Biol; 2023 Apr; 157():106395. PubMed ID: 36871936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apigenin Enhanced Antitumor Effect of Cisplatin in Lung Cancer via Inhibition of Cancer Stem Cells.
    Li Y; Chen X; He W; Xia S; Jiang X; Li X; Bai J; Li N; Chen L; Yang B
    Nutr Cancer; 2021; 73(8):1489-1497. PubMed ID: 32757802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A micellar cisplatin prodrug simultaneously eliminates both cancer cells and cancer stem cells in lung cancer.
    Zhu YH; Sun CY; Shen S; Khan MIU; Zhao YY; Liu Y; Wang YC; Wang J
    Biomater Sci; 2017 Jul; 5(8):1612-1621. PubMed ID: 28580971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-targeting tumor cells hybrids derived from Pt(IV) species and NF-κB inhibitors enables cancer therapy through mitochondrial dysfunction and ER stress and overcomes cisplatin resistance.
    Wang M; Li G; Jiang G; Cai J; Zhong W; Huang R; Liu Z; Huang X; Wang H
    Eur J Med Chem; 2024 Feb; 266():116095. PubMed ID: 38215589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Platinum(IV) Anticancer Prodrug Targeting Nucleotide Excision Repair To Overcome Cisplatin Resistance.
    Wang Z; Xu Z; Zhu G
    Angew Chem Int Ed Engl; 2016 Dec; 55(50):15564-15568. PubMed ID: 27736029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased MicroRNA-26a expression causes cisplatin resistance in human non-small cell lung cancer.
    Yang Y; Zhang P; Zhao Y; Yang J; Jiang G; Fan J
    Cancer Biol Ther; 2016 May; 17(5):515-25. PubMed ID: 26492332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platinum (IV)-fatty acid conjugates overcome inherently and acquired Cisplatin resistant cancer cell lines: an in-vitro study.
    Ratzon E; Najajreh Y; Salem R; Khamaisie H; Ruthardt M; Mahajna J
    BMC Cancer; 2016 Feb; 16():140. PubMed ID: 26906901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.